Immunohistochemical staining for LAMP-1 (CD107a) of CT26.CL25 tumors. by Pawel Mroz (156435)

“…<p>A. non-treated control. B. negative control for staining. …”

Groundwater and stream (a) C-DIC values and (b) DIC concentrations from headwater catchments in Sweden (left) and Canada (right). by Jason J. Venkiteswaran (532155)

“…At these two sites where we have both groundwater and stream data, there is a clear increase in C-DIC values from groundwater to stream sampling points along with a large decrease in DIC concentration.…”

Success of a weight loss plan for overweight dogs: The results of an international weight loss study by John Flanagan (301063)

“…<div><p>Introduction</p><p>Obesity is a global concern in dogs with an increasing prevalence, and effective weight loss solutions are required that work in different geographical regions. …”

Altered adaptive responses to a novel environment in <i>Slitrk6</i>-KO mice. by Yoshifumi Matsumoto (257936)

“…<p>(A, B) Open field test. (A) The total distance moved was less in <i>Slitrk6</i>-KO than in WT mice (left). …”

Score on a mathematics diagnostic assessment and its dependence on affective aspects due to making mistakes by Cristina Eccius-Wellmann (5552084)

EHV-1 induces platelet activation in equine platelet-rich plasma in a concentration-dependent manner. by Tracy Stokol (718195)

“…RacL11 induced slightly stronger microvesiculation than Ab4, with a decrease in P-selectin expression at the higher PFU/cell of 1 and 5. * p < 0.001 for P-selectin and p = 0.002 for PDMP versus RK, 0.01 and 0.1 PFU/cell for each virus strain (except Ab4 at 0.5 PFU/cell was not significantly different from RK). ** p < 0.001 versus Ab4.…”

Supplementary Material for: A case report: Metastatic Gestational Trophoblastic Neoplasia leading to acute respiratory failure and death. About a particularly challenging managemen... by figshare admin karger (2628495)

Supplementary Material for: The Prevalence of Active Epilepsy in the Kingdom of Saudi Arabia : A cross sectional study by AlRymayyan A. (13921932)

“…Structural, vascular, and focal abnormalities were the most commonly diagnosed abnormalities (18.2%, 14.5%, and 39.2%, respectively). Conclusion: The prevalence of active epilepsy in KSA has dramatically decreased during the last decades to a rate lower than those reported in most developing countries. …”

Clinical effectiveness and cost-effectiveness as a function of PrEP adherence, HIV prevalence and behavioral disinhibition. by Anders Chen (640309)

Age at treatment initiation–cross sex hormones. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Study characteristics. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Age at treatment initiation–puberty suppression. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Search terms. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

PRISMA diagram. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

PRISMA 2020 checklist. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Supplementary Material for: Immune Dysregulation in Chronic Stress: A Quantitative and Functional Assessment of Regulatory T Cells by Kim H.-R. (4129201)

Erratum: Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs by Mitchell J. (4275088)

Enhancing the quality attributes of salad dressing by incorporating Gac aril as a biologically active ingredient by Phisut Naknaen (5695982)

“…An increase in GA content caused a marked increase in the soluble fibre, lycopene and total phenolic contents while the fat content and the caloric value decreased. …”

Catalysis of Alkene Epoxidation by a Series of Gallium(III) Complexes with Neutral N‑Donor Ligands by Wenchan Jiang (1957537)

A sequential radiation-sorafenib regimen is most efficacious against HCC <i>in vivo</i>. by Aaron T. Wild (418957)

“…<p>A HepG2 hind-flank xenograft model was utilized to measure the efficacy of (A) 5 different treatment arms: control (sham injection of vehicle control on days 1–5), sorafenib alone (SOR; injection of 6 mg/mL sorafenib on days 1–5), radiation alone (RT; irradiation at a dose of 3 Gy on days 1–3), concurrent radiation-sorafenib (CONC; sorafenib injection on days 1–5 and irradiation at a dose of 3 Gy on days 2–4), and sequential radiation-sorafenib (SEQ; irradiation at a dose of 3 Gy on days 1–3 and sorafenib injection on days 4–8). …”